Taking a bite out of bias: Solventum’s teeth-centric approach to randomization

Webinar hosted by Zelta by Merative and Solventum

17

October

  • 11am New York | 4pm London
  • Free

Why attend?

Designing and running a clinical trial involves making many decisions that are unique to the needs of that trial. Central to robust trial design is an effective randomization strategy, but traditional methods aren’t always the best fit. Sometimes what’s best for the trial requires some outside-of-the-box thinking.

Join Zelta by Merative and Solventum for an insightful discussion on the importance of randomization in clinical trials and how an innovative approach focused on the enrolling of teeth successfully reduced selection bias.

This session will explore the unique challenges faced in clinical trial randomization, Solventum’s story of reducing bias by randomizing participant’s teeth, and how a flexible EDC platform like Zelta can help enable novel solutions like these to meet the unique needs of clinical trials.

 

    • Explore the benefits of using a flexible platform for internal research studies and traditional clinical trials
    • Discover how Zelta helped enable Solventum’s strategy of randomizing teeth and how this led to reduced selection bias

Speakers

Select a speaker to learn more

Back
Jennifer Duff
Executive Vice President and General Manager, Zelta by Merative

Jennifer Duff has over 25 years of experience in the Life Sciences industry with specialization in enabling and scaling industry-leading services and technology solutions for biopharma clients.  She has collaborated with teams across the Life Sciences industry, from large to mid-sized companies, as well as many of the major technology providers over her career.

Jennifer has an MBA in Biotechnology and Healthcare Management.  Her focus is on challenging industry norms and seeking powerful, novel solutions that drive business growth and deliver improved outcomes for Life Sciences clients and the patients they serve.

Next speaker
Back
Krista Dahling
Supervisor, Clinical Data Management | Solventum

Krista Dahling supervises the Data Management Team at Solventum, previously known as 3M Health Care. She has worked at 3M/Solventum for over 35 years in the health care business; the last 24 in Clinical Research. Solventum conducts mainly phase 1-3 medical device clinical trials. Her team manages on average 45 studies at any given time within the development, execution, and close-out phases. Over the past 18 years, Krista has used several different EDC platforms; she started using Zelta in 2021. She enjoys working in Clinical Research because of the positive impact she can make on others which changes their life for the better.

Next speaker

Enquiry